CD8A and cancer: Similarly, elevated protein levels of TMEM176B are detected in multiple malignancies, moreover, inhibition of TMEM176B has already been proved to promote CD8+ T cell-mediated tumor growth control, enhancing the therapeutic efficacy of cancers [45, 46].